Thiophene–Amino Acid Hybrid Structures
FULL PAPER
(ESI-TOF): m/z calcd for C40H44N4O8S2+Na+: 795.2493 [M+Na]+;
found: 795.2493; rac-7: 1H NMR (500 MHz, CDCl3, CD3OD): d=1.26 (s,
18H; tBu), 2.81, 3.02 (2dd, J=7.8, 14.2 Hz and 7.8, 14.2 Hz, 2H each;
CH2Ph), AB system (dA =3.15, dB =3.24, JAB =13.0 Hz, 4H; CH2), 4.80
(t, J=7.8 Hz, 2H; COCHN), 6.62 (s, 2H; Hthioph), 6.92–7.03 ppm (m,
10H; Ph); 13C NMR (126 MHz, CDCl3, CD3OD): d=27.4 (q; tBu), 34.7
(t; CH2Ph), 37.2 (t; CH2), 54.1 (d; COCHN), 81.3 (s; tBu), 114.9 (s;
CCO2-tBu), 123.3 (d; CHthioph), 126.4 (s; SCCH2), 127.12, 128.1, 128.6,
136.1 (3d, s; Ph), 144.7 (s; SCN), 162.9 (s; CO2tBu), 167.0 (s; NCOCH),
171.3 ppm (s; NHCOCH2); meso-7: 1H NMR (500 MHz, CDCl3,
CD3OD): d=1.32 (s, 18H; tBu), 2.72, 2.84 (2dd, J=7.8, 14.2 Hz for both,
2H each; CH2Ph), AB system (dA =3.108/3.110, dB =3.45, JAB =13.8 Hz,
4H; CH2), 4.70 (t, J=7.8 Hz, 2H; COCHN), 6.71 (s, 2H; Hthioph), 6.92–
7.03 ppm (m, 10H; Ph); 13C NMR (126 MHz, CDCl3, CD3OD): d=27.5
(q; tBu), 35.5 (t; CH2Ph), 37.8 (t; CH2), 55.2 (d, COCHN), 81.5 (s; tBu),
114.6 (s; CCO2tBu), 123.5 (d; CHthioph), 126.5 (s; SCCH2), 127.08, 128.08,
128.5, 135.7 (3d, s; Ph), 145.2 (s; SCN), 163.4 (s; CO2tBu), 167.5 (s;
NCOCH), 172.0 ppm (s; NHCOCH2).
Amide (S)-3: A solution of aminothiophene 1 (1.00 g, 3.69 mmol), l-phe-
nylalanine derivative 2 (1.30 g, 4.34 mmol), and T3P (2.00 g, 6.46 mmol)
in CH2Cl2 (25 mL) was ultrasonicated and Et3N (0.359 g, 3.66 mmol) was
slowly added. Following the addition, the mixture was further sonicated
for 6 h. EtOAc was then added and the mixture was washed with water.
The organic phase was dried with Na2SO4 and the solvent was removed
under reduced pressure. Purification of the residue by column chroma-
tography (silica gel; hexanes/EtOAc, 4:1) gave amide (S)-3 (1.79 g, 92%,
>99% ee) as a colorless solid. The enantiomeric excess was determined
by HPLC analysis (20% isopropanol in hexanes, 0.7 mLminꢀ1). M.p. 41–
448C; [a]2D2 =ꢀ31.5 (c=0.75 in CHCl3); the NMR data were consistent
with those of racemic 3; HRMS (ESI): m/z calcd for C29H32N2O7S+Na+:
575.1828 [M+Na]+; found: 575.1852.
Amide (S)-4: LiOH (36.4 mg, 1.52 mmol) was added in small portions to
a solution of enantiopure (S)-3 (0.840 g, 1.52 mmol) in THF (10 mL) and
H2O (4 mL) at 08C and the mixture was stirred for 6 h at 08C. It was
then acidified to pH 2–3 with HCl (1m) and extracted with EtOAc. The
organic phase was washed with water until the washings were neutral and
dried with Na2SO4. The solvent was removed under reduced pressure and
the residue was purified by column chromatography (silica gel; CH2Cl2/
MeOH, 9:1) to afford amide (S)-4 (0.550 g, 67%, 94% ee) as a colorless
solid. The enantiomeric excess was determined by HPLC analysis (30%
isopropanol in hexanes, 0.7 mLminꢀ1). M.p. 68–718C; [a]D22 =ꢀ35.4 (c=
0.98 in CHCl3); the NMR data were consistent with those of racemic 4;
HRMS (ESI): m/z calcd for C28H30N2O7S+Na+: 561.1666 [M+Na]+;
found: 561.1687.
Data for the individual diastereomers:
Compound rac-7: Melting range 76–818C; [a]2D2 = +4.7 (c=0.11 in
CHCl3); 1H NMR (500 MHz, [D6]DMSO): d=1.51 (s, 18H; tBu), 2.99,
3.17 (2dd, J=8.1, 13.8 Hz for both, 2H each; CH2Ph), AB system (dA =
3.30, dB =3.43, JAB =12.7 Hz, 4H; CH2), 4.68–4.72 (m, 2H; COCHN),
6.75 (s, 2H; Hthioph), 7.20–7.23, 7.29–7.32, 7.36–7.38 (3m, 2H, 4H, 4H;
Ph), 8.97 (d, J=7.2 Hz, 2H; NH), 10.30 ppm (s, 2H; NH); 13C NMR
(101 MHz, [D6]DMSO): d=27.9 (q; tBu), 34.4 (t; CH2Ph), 37.0 (t; CH2),
54.3 (d; COCHN), 81.2 (s; tBu), 114.0 (s; CCO2tBu), 123.0 (d; CHthioph),
126.5 (s; SCCH2), 128.2, 128.3, 129.3, 137.6 (3d, s; Ph), 145.1 (s; SCN),
162.6 (s; CO2tBu), 167.8 (s; NCOCH), 170.4 ppm (s; NHCOCH2).
Compound meso-7: M.p. 173–1768C; [a]2D2 = +5.4 (c=0.37 in CHCl3/
CH3OH, 1:1); 1H NMR (500 MHz, [D6]DMSO): d=1.56 (s, 18H; tBu),
2.91, 3.06 (2dd, J=9.3, 13.7 Hz and 6.2, 13.7 Hz, 2H each; CH2Ph), AB
system (dA =3.17, dB =3.65, JAB =13.2 Hz, 4H; CH2), 4.62–4.66 (m, 2H;
COCHN), 6.90 (s, 2H; Hthioph), 7.19–7.22, 7.27–7.30, 7.33–7.35 (3m, 2H,
4H, 4H; Ph), 8.58 (d, J=8.4 Hz, 2H; NH), 10.50 ppm (s, 2H; NH);
13C NMR (101 MHz, [D6]DMSO): d=28.0 (q; tBu), 34.9 (t; CH2Ph), 37.8
(t; CH2), 55.4 (d; COCHN), 81.3 (s; tBu), 113.8 (s; CCO2tBu), 123.2 (d;
CHthioph), 126.6 (s; SCCH2), 127.9, 128.3, 129.3, 137.3 (3d, s; Ph), 145.5 (s;
SCN), 163.1 (s; CO2tBu), 168.3 (s; NCOCH), 171.2 ppm (s; NHCOCH2).
Amide (S)-5: Cyclohexene (3.5 mL) and Pd/b (98%, 0.200 g) were added
to
a solution of enantiopure (S)-3 (0.940 g, 1.70 mmol) in MeOH
(3.5 mL) and the mixture was heated at reflux for 24 h. After cooling, it
was filtered through Celite and the solvent was removed under reduced
pressure. Chromatographic purification of the residue (silica gel; CH2Cl2/
EtOAc, 9:1) afforded (S)-5 (0.614 g, 86%, 99% ee) as a yellow solid. The
enantiomeric excess was determined by HPLC analysis (20% isopropa-
nol in hexanes, 0.7 mLminꢀ1). [a]D22 =ꢀ39.6 (c=1.0 in CHCl3); the NMR
data were consistent with those of racemic 5.
Triamide (S,S)-6a: T3P (0.501 g, 1.62 mmol) was added to a solution of
enantiopure (S)-4 (0.500 g, 0.928 mmol) and enantiopure (S)-5 (0.466 g,
1.11 mmol) in CH2Cl2 (25 mL). The solution was activated by ultrasound
and Et3N (0.094 g, 0.928 mmol) was added dropwise. The mixture was so-
nicated for 2 h. EtOAc was then added and the mixture was washed with
water. The organic phase was dried with Na2SO4 and the solvent was re-
moved under reduced pressure. Purification of the residue by column
chromatography (silica gel; CH2Cl2/EtOAc, 9:1) gave enantiopure (S,S)-
6a (0.808 g, 93%, 99% ee) as a colorless solid. The enantiomeric excess
was determined by HPLC analysis (30% isopropanol in hexanes,
0.7 mLminꢀ1). M.p. 83–868C; [a]D22 =ꢀ13.9 (c=0.38 in CHCl3); 1H NMR
(500 MHz, CDCl3): d=1.53, 1.54 (2s, 9H each; tBu), 3.07–3.11, 3.19–3.26
Synthesis of enantiomerically pure (S,S)-7: PyBOP (0.157 g, 0.302 mmol)
and DMAP (0.062 g, 0.504 mmol) were added to a solution of triamide
(S,S)-6c (0.199 g, 0.252 mmol) in CH2Cl2 (63 mL) at 08C. The mixture
was stirred for 2 d at room temperature. It was then diluted with CH2Cl2,
and the organic phase was washed with 1m HCl, saturated NaHCO3, and
saturated NaCl solutions, and then dried with Na2SO4. The solvent was
then evaporated under reduced pressure. Purification by column chroma-
tography (silica gel; hexanes/EtOAc, 2:1!1:1) afforded (S,S)-7 (0.094 g,
51%, d.r.ꢁ98:2) as a colorless solid. The ratio of diastereomers was de-
termined by HPLC (5% isopropanol in hexanes, 1.5 mLminꢀ1). Traces of
the meso-7 diastereomer (4 mg, 2%) could be separated by an additional
HPLC purification together with 0.087 g of the desired (S,S)-7 (45%)
with a d.r.>99:1. M.p. 162–1668C; [a]2D2 = +162.8 (c=1.03 in CHCl3);
1H NMR (700 MHz, [D6]DMSO): d=1.52 (s, 18H; tBu), 2.30, 3.17 (2dd,
J=9.8, 13.7 Hz and 5.4, 13.7 Hz, 2H each; CH2Ph), AB system (dA =
3.30, dB =3.44, JAB =12.8 Hz, 4H; CH2), 4.68–4.72 (m, 2H; COCHN),
6.75 (s, 2H; Hthioph), 7.20–7.23, 7.29–7.32, 7.36–7.37 (3m, 2H, 4H, 4H;
Ph), 8.95 (d, J=9.2 Hz, 2H; NH), 10.28 ppm (s, 2H; NH); 13C NMR
(126 MHz, [D6]DMSO): d=27.8 (q; tBu), 34.4 (t; CH2Ph), 37.0 (t; CH2),
54.2 (d; COCHN), 81.1 (s; tBu), 113.9 (s; CCO2tBu), 122.9 (d; CHthioph),
126.4 (s; SCCH2), 128.1, 128.2, 129.2, 137.5 (3d, s; Ph), 145.0 (s; SCN),
162.5 (s; CO2tBu), 167.7 (s; NCOCH), 170.3 ppm (s; NCOCH2); IR
(2m, 1H, 3H; CH2Ph), AB system (dA =3.64, dB =3.64/3.78, JAB
17.2 Hz, 2H; CH2), 3.70 (s, 2H; CH2), 3.72 (s, 3H; OMe), 4.73–4.77,
4.88–4.92 (m, 1H each; COCHN), AB system (dA =5.10, dB =5.14, JAB
=
=
12.3 Hz, 2H; CH2Ph), 5.42–5.45, 6.19–6.22 (2m, 1H each; NH), 6.93, 6.96
(2s, 1H each; Hthioph), 6.98–7.00, 7.13–7.14, 7.18–7.22, 7.25–7.26, 7.28–7.34
(5m, 2H, 3H, 3H, 2H, 5H; Ph), 11.37, 11.39 ppm (brs, s, 2H; NH);
13C NMR (126 MHz, CDCl3): d=28.3, 28.4 (2q; tBu), 35.0, 36.8 (2t;
CH2-thioph), 37.5, 38.3 (2t; CH2Ph), 52.5 (q; OMe), 54.3, 56.4 (2d;
COCHNH), 67.5 (t; OCH2Ph), 81.95, 82.0 (2s; tBu), 114.9, 115.2 (2s; C-
CO2tBu), 123.8, 124.8 (2d; CHthioph), 125.0, 125.3 (2s; SCCH2), 127.3,
127.4, 128.2, 128.3, 128.6, 128.9, 129.0, 129.2, 129.3, 135.3, 135.7, 136.1
(9d, 3s; Ph), 146.8, 147.0 (2s; SCNH), 156.0 (s; Cbz), 164.5, 164.8 (2s;
CO2tBu), 167.8, 168.4, 169.5 (3s; CHCONH), 170.7 ppm (s, CO2Me);
HRMS (ESI): m/z calcd for C49H54N4O11S2+Na+: 961.3123 [M+Na]+;
found: 961.3129.
ꢀ
ꢀ
ꢀ
(ATR): n˜ =3280 (N H), 3110–2930 (=C H, C H), 1670 (C=O), 1560–
1525 cmꢀ1 (C=C); HRMS (ESI-TOF): m/z calcd for C40H44N4O8S2+Na+:
795.2493 [M+Na]+; found: 795.2509.
Triamide (S,S)-6b: Hydrogen gas was flushed through a suspension of
10% Pd/C (0.500 g) in MeOH (15 mL) for 15 min. A solution of carba-
mate (S,S)-6a (0.890 g, 0.948 mmol) in CH2Cl2 (5 mL) was then added
and hydrogen gas was flushed through the mixture for 16 h (TLC con-
trol). The mixture was then filtered through Celite and the solvent was
removed under reduced pressure. Chromatographic purification (silica
Synthesis of enantiopure oligoamides (S)-3, (S)-4, (S)-5, (S,S)-6a, (S,S)-
6b, (S,S)-6c, and (S,S)-7 by employing the ultrasound and T3P-promoted
protocol:
Chem. Eur. J. 2013, 19, 15155 – 15165
ꢂ 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
15163